Two-stage reconstruction of critical-size segmental bone defects using an induced vascularised biomembrane | advanced
Surgical Imaging
The trap: Stopping debridement when bone looks 'clean' rather than when healthy bleeding bone is reached — residual necrotic bone leads to persistent infection and graft failure.
The fix: Debride until punctate bleeding is seen from all bone surfaces (the 'paprika sign'); use high-speed burr or curettes under irrigation to reach viable bone. In infected cases send multiple deep tissue and bone samples for culture before inserting the spacer.
The trap: Incising or tearing the induced membrane during spacer removal or graft packing — once torn the membrane loses its containment and inductive properties.
The fix: Make a single longitudinal incision through the membrane only; use blunt dissection and periosteal elevators to elevate it gently as a continuous sheet from the surrounding soft tissues. Protect it with moist packs throughout the procedure.
The trap: Converting from external fixation in stage one to definitive internal fixation too early in stage two without confirming infection clearance — hardware becomes a nidus for recurrent infection.
The fix: In infected defects keep external fixation until stage two and only then consider conversion to plate or nail once cultures from stage two are negative. For aseptic defects, internal fixation can be used from stage one provided soft-tissue coverage is adequate.
The trap: Proceeding to stage two while low-grade infection persists — the graft will be resorbed or become infected.
The fix: Stage two is only performed when clinical signs of infection have resolved, inflammatory markers (CRP, ESR) have normalised, and there is no ongoing drainage. If doubt exists, repeat debridement and spacer exchange rather than grafting into an infected bed.
The trap: Underestimating autograft volume required — defects greater than 5 cm often need more than 50-100 mL of cancellous graft, leading to excessive iliac crest harvest morbidity.
The fix: Plan graft volume pre-operatively using CT; use posterior iliac crest (higher volume, less pain than anterior), consider RIA (reamer-irrigator-aspirator) from the femur for large-volume harvest, and use allograft/BMA extenders liberally.
The trap: Leaving the external fixator in place for the entire consolidation period (greater than 6 months) — pin-site infection, joint stiffness and patient intolerance increase dramatically.
The fix: Convert to internal fixation (plate or intramedullary nail) at stage two once the membrane is closed and graft is in place, provided soft tissues are healthy. External fixation is maintained only until stage two in most trauma cases.
M.A.S.Q.U.E.L.E.TMASQUELET — Two-Stage Principles
D.E.F.E.C.TDEFECT — Decision Framework for Segmental Bone Loss
Indications for the Masquelet Technique
Primary Indications
- Post-traumatic segmental bone loss greater than 2 cm after high-energy open fractures (Gustilo IIIB/C)
- Infected nonunion with bone defect after radical debridement (most common indication)
- Aseptic nonunion with segmental defect after failed prior fixation
- Bone defects after tumour resection (primary bone tumours or metastases) when limb salvage is planned
- Congenital pseudarthrosis of the tibia or other dysplastic segmental defects (selected cases)
Contraindications
Absolute:
- Active uncontrolled infection with systemic sepsis
- Inadequate soft-tissue envelope that cannot be reconstructed
- Severe peripheral vascular disease precluding graft vascularisation
- Patient unable or unwilling to comply with staged surgery and prolonged rehabilitation
Relative:
- Defects less than 2 cm (direct autografting or acute shortening preferable)
- Defects greater than 8-10 cm in the tibia (bone transport or free vascularised fibula may be superior)
- Heavy smokers or poorly controlled diabetics (optimise first or consider alternative)
Evidence Base and Outcomes
The original description by Masquelet in 2000 reported union in 35 of 35 patients with defects averaging 4.7 cm using the two-stage technique. Subsequent series have confirmed union rates of 80-95% for defects 2-6 cm when radical debridement and stable fixation are achieved.
Key advantages over alternative techniques:
- Simpler than vascularised fibula transfer (no microsurgery required)
- Shorter treatment time than Ilizarov bone transport for moderate defects
- The membrane provides both mechanical containment and biological induction, improving graft survival compared with grafting into scarred tissue
Limitations:
- Requires two major operations
- Autograft donor-site morbidity for large defects
- Not ideal for very long defects (greater than 8 cm) where transport or vascularised graft may be better
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 42-year-old man sustains an open Gustilo IIIB fracture of the tibial shaft with 5 cm segmental bone loss after a motorbike accident. He undergoes initial debridement and external fixation. At 6 weeks there is no infection but a persistent 5 cm defect. How would you reconstruct this?”
“Six months after stage-two Masquelet grafting for a 6 cm tibial defect, radiographs show incomplete consolidation at the proximal host-graft junction with 3 mm lucency and no bridging callus. The patient has mild discomfort but no signs of infection. What is your management?”
“A 35-year-old woman with an infected nonunion of the femur after failed exchange nailing has a 7 cm segmental defect. She is a heavy smoker. Compare the Masquelet technique with Ilizarov bone transport and vascularised fibula transfer for this patient.”